Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × OTHER × Vaccine Effectiveness × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 456 Neoplasms 342 Colorectal Neoplasms 234 Carcinoma, Non-Small-Cell Lung 225 Lung Neoplasms 198 Prostatic Neoplasms 179 Carcinoma, Hepatocellular 168 Stomach Neoplasms 138 Pancreatic Neoplasms 115 Rectal Neoplasms 105 Uterine Cervical Neoplasms 104 Leukemia, Myeloid, Acute 103 Multiple Myeloma 94 Squamous Cell Carcinoma of Head and Neck 91 Recurrence 83 Neoplasm Metastasis 77 Head and Neck Neoplasms 76 Ovarian Neoplasms 72 Brain Neoplasms 70 Triple Negative Breast Neoplasms 67 Esophageal Neoplasms 66 Colonic Neoplasms 66 Glioblastoma 65 Motor Activity 59 Endometrial Neoplasms 58 Precursor Cell Lymphoblastic Leukemia-Lymphoma 57 Hematologic Neoplasms 52 Small Cell Lung Carcinoma 50 Glioma 49 Disease 48

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07256912 2026-03-24

CervALONE

International Agency for Research on Cancer

Phase 4 Not yet recruiting

Vaccine Effectiveness

Data powered by HemOnc (CC BY 4.0) Colophon ⚡